The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy DevelopmentNallasivam Palanisamy, Nora M. Navone, Jun Yang et al.|Clinical Cancer Research|2020Cited by 86
Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate CancerEstefanía Labanca, Nora M. Navone, Jun Yang et al.|European Urology Oncology|2021Cited by 28
Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) SeriesNicolás Anselmino, Nora M. Navone, Estefanía Labanca et al.|Clinical Cancer Research|2024Cited by 28
Data from Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) SeriesNicolás Anselmino, Nora M. Navone, Sumit K. Subudhi et al.|Unknown|2024Cited by 1
Abstract 4674: Targeting cancer stem-cells in aggressive variant prostate cancersRama Soundararajan, Sendurai A. Mani, Paul Allegakoen et al.|Tumor Biology|2019Cited by 1